Nephros stockholders approve 2024 Equity Incentive Plan authorizing 2,616,875 shares

NEPHROS INC

Plan adds 900,000 new shares plus prior plan reserve and returning shares; total shares authorized 2,616,875.
Stockholders elected directors Arthur H. Amron (6,860,037 for) and Oliver Spandow (6,690,864 for).
Ratified Baker Tilly US, LLP as independent auditor for FY2024 (8,545,420 for, 21,330 against).
Advisory say-on-pay approved with 6,832,340 for, 62,907 against.
Prior plan no longer available for new grants; all outstanding awards remain subject to prior terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.